The table below shows Immunocore Holdings plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$106.68M
$103.69M
$97.96M
$93.88M
$80.25M
$75.40M
Cost of revenue
$434.00K
$513.00K
$1.04M
$831.00K
$448.00K
$1.71M
Gross profit
-
-
-
-
-
-
R&D
$61.11M
$70.57M
$69.01M
$56.47M
$52.77M
$51.07M
IMCR annual revenue (10-K history)
Immunocore Holdings plc reported annual revenue of $400.02M for fiscal year 2025. That is up 29.0% from $310.20M in fiscal 2024. Over the 5 fiscal years shown, annual revenue grew from $36.48M (FY 2021) to $400.02M. Figures come from the company's audited annual reports as filed with the SEC.